Medical Developments International Limited

MVP

Medical Developments International Ltd. engages in the manufacture and distribution of pharmaceutical drugs, medical, and veterinary equipment. The company is headquartered in Melbourne, Victoria. The company went IPO on 2003-12-15. The firm operates in two segments: Pain Management and Respiratory. The Pain Management segment is engaged in the supply of analgesia for acute and procedural pain. The firm manufactures inhaled analgesic, Penthrox (the Green Whistle), at manufacturing facilities at Scoresby and Springvale in Victoria, Australia. Penthrox is sold into domestic and international markets through distribution partnerships and direct in-market capability. The Respiratory segment is a supplier of respiratory products including asthma and chronic obstructive pulmonary disease (COPD) space chambers, peak flow meters, portable nebulizers and silicone face masks. Respiratory supplies into Australia, the United States of America, Europe, and Asia through partnerships with distributors.

Auckland International Airport Limited

AIA

Auckland International Airport Ltd. engages in the provision of airport facilities and supporting infrastructure. The firm's segments include Aeronautical, Retail and Property. Its aeronautical business provides services that facilitate the movement of aircraft, passengers and cargo and provides utility services that support the airport. The aeronautical business also earns rental revenue from space leased in facilities such as terminals. Its retail business provides services to the retailers within the terminals and provides car parking facilities for passengers, visitors, and airport staff. Its property business earns rental revenue from space leased on airport land outside the terminals, including cargo buildings, hangars, shops, and other stand-alone investment properties. Its consumer segment includes the provision of amenities for retail businesses both in the terminal and within the surrounding precinct.

Brickworks Limited

BKW

Brickworks Ltd. engages in the manufacture and distribution of building products. The company is headquartered in Sydney, New South Wales and currently employs 2,193 full-time employees. The firm's Building Products Australia segment is engaged in the manufacturing of vitrified clay and concrete products used in the building industry. The major product lines in this segment include bricks, masonry blocks, pavers, roof tiles, floor tiles, fiber cement walling panels and roof battens. The Building Products North America segment is engaged in the manufacturing of vitrified clay and concrete products used in the building industry. The major product lines in this segment include bricks and masonry blocks. The Industrial Property segment is engaged in the utilization of opportunities associated with land owned by the Company, including the sale of property and investment in property trusts. The Investments segment holds investments in the Australian share market, both for dividend income and capital growth, and includes the investment in Washington H. Soul Pattinson and Company Limited and FBR Limited (FBR).

Commonwealth Bank of Australia

CBA

Commonwealth Bank of Australia engages in the provision of banking and financial services. The company is headquartered in Sydney, New South Wales and currently employs 48,860 full-time employees. The firm provides retail and commercial banking services predominantly in Australia and in New Zealand through its subsidiary, ASB. The company serves approximately 16 million customers. The firm's segments include Retail Banking Services, Business Banking, Institutional Banking and Markets and New Zealand. Retail Banking services provides banking and general insurance products and services to personal and private bank customers. Business Banking serves the banking needs of business, corporate and agribusiness customers across the full range of financial services solutions, as well as providing equities trading and margin lending services through the CommSec business. Institutional Banking and Markets serves the commercial and wholesale banking needs of large corporate, institutional and government clients. New Zealand includes the banking and funds management businesses operating under the ASB brand.

Alcidion Group Limited

ALC

Alcidion Group Ltd. engages in the development and provision of healthcare software products marketed under the Miya, Patientrack, Smartpage and ExtraMed brands. The company is headquartered in Melbourne, Victoria. The company went IPO on 2011-06-24. Its principal activities include the development and licensing of its own healthcare software products (Miya Precision and its associated modules, including Miya Observations, Flow, Task Management and PAS), the reselling of selected healthcare software products from its strategic partners and the delivery of product implementation, product support and maintenance, systems integration, and data analysis services to healthcare customers in Australia, New Zealand, and the United Kingdom. Its flagship product, Miya Precision, is a smart clinical solution based on a FHIR-event platform that facilitates multiple clinical and operational applications. Its other products include Smartpage, Patientrack, and Silverlink PCS. Smartpage is an advanced smartphone and Web-based system for hospital communication and task management, addressing the requirements of both clinical and non-clinical users. The firm services over 400 hospitals.